Trading Options with an Edge
Select Page

EDIT

Search by
TICKER SYMBOL

Editas Medicine Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

12.23

0.07

(0.576%)

Volume:

1,464,427

52 week range:

9.59 - 42.11

Market Cap:

840.657M

Company Description:

As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.